Bioceres Crop Solutions Corp. Ordinary Shares (BIOX)

FairStock Score: 35/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach this as a Graham-style bargain hunt, but the first duty is not to lose capital. Bioceres sells seeds, crop protection, and crop nutrition—useful products, yet the financials show a business under strain. In the latest reported quarter, fiscal Q1 2026, revenue was $38.2M and net income was -$9.0M, a -23.56% net margin. The provided growth measures are negative, so the trajectory is shrinking and deeply unprofitable. FairStock's calculated return measures at the 2026-10-13 close of $0.32 show a negative P/E of -0.44, price-to-book of 0.08, ROE of -28.05%, ROCE of -0.05%, and debt-to-equity of 3.69. That leverage, combined with an Altman Z-Score of 0.01 and a Piotroski F-Score of 4/9, suggests financial distress rather than a fortress balance sheet. The one flashing green light is cash generation: trailing twelve-month free cash flow was $72.2M, giving a FairStock FCF yield of 184.7% against a $39.1M market cap. If that cash flow is real, recurring, and not a working-capital accident, the market is pricing the equity at a tiny fraction of its cash-generating ability. But the reported losses, negative margins, and high debt make me skeptical. A moat is not evident from the numbers; agricultural inputs can be competitive and cyclical. FairStock's Lynch category is none because there are not three years of filed results. At this price, the asset value and cash flow scream cheap, but the income statement and balance sheet scream danger. I would need evidence that cash flow is durable and debt is manageable before calling it a safe bargain.

In plain English: Bioceres sells seeds, crop protection, and crop nutrition products to farmers. The business is currently losing money, sales have been falling, and it carries a lot of debt for its size. The stock price is very low compared with its accounting value and cash flow, but the weak profits and high debt make it look risky rather than clearly cheap.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer